Crystals of ~-chloro-~-valerolactam are monoclinic with space group P2~/e and Z= 4. The lattice constants at room temperature are a=11.73, b=6-20, c=9.51 A., ,8=112-0 °. The structure was solved from a minimum function M4 which was directly computed and contoured at the machine output. Both b-and c-axis data were refined separately with a least-squares program and the results are compared. The molecule has a half-chair conformation with the chlorine atom in equatorial position. The peptide linkage NH-CO has the cis configuration. Unusual bond lengths are not observed.

Purpose The aim of this study is to determine nitrofurantoin exposure in patients with different age and renal function with complaints of an uncomplicated UTI. Also the nitrofurantoin exposure in relation to the dosage regimen will be studied. Methods Eight general practitioners (GP) participated in the study and included 38 patients with symptoms of an uncomplicated UTI, treated either with a dose of 50 mg q6h or 100 mg q12h, upon the discretion of the GP. Nitrofurantoin exposure was quantified in the patient’s 24 hours urine samples by UHPLC-UV and the area under the curve was calculated. Results The 38 patients provided a range of 2-17 urine samples. The urine nitrofurantoin exposure was 1028 mg.h/L for the patients receiving 50 mg q6h and 1036 mg.h/L for those treated with 100 mg q12h (p=0.97) and was not affected by age and eGFR (p= 0.64 and p=0.34, respectively). The clinical cure rate of 87% was independent of the dose regimens and the nitrofurantoin exposure. Conclusion The data obtained do not support the discouragement of nitrofurantoin use in the elderly and in patients with impaired renal function. Since only a small number of patients were included, a larger study with more patients is warranted to evaluate nitrofurantoin exposure and adverse effects.